Recombinant Human ATG3 Protein ，His & SUMO

ATG3, a key protein in the autophagy process, plays a fundamental role in the formation of autophagosomes, which are essential for cellular homeostasis and the degradation of damaged organelles and proteins. It is a member of the autophagy-related (ATG) protein family and functions as an E2-like enzyme, facilitating the conjugation of the ubiquitin-like protein LC3 to phosphatidylethanolamine (PE) during autophagosome formation. This conjugation is crucial for the maturation of autophagosomes and their subsequent fusion with lysosomes. Research has increasingly focused on ATG3 due to its implications in various physiological processes and disease states, including cancer, neurodegenerative disorders, and infections. Dysregulation of autophagy, where ATG3's activity may be altered, has been associated with the pathogenesis of these diseases, making ATG3 an attractive target for therapeutic interventions. Furthermore, understanding the mechanistic details of ATG3’s interactions with other autophagy-related proteins can provide insights into the broader regulatory networks of autophagy, potentially uncovering new avenues for drug development and treatment strategies. As such, ongoing studies aim to delineate the structural features and functional dynamics of ATG3, identifying how modifications in its expression or activity could influence overall autophagic processes within cells. This increasing interest in ATG3 underscores its importance not only in basic cellular biology but also in its potential clinical applications, highlighting the need for continued investigation into this crucial protein's role within the autophagic machinery.